name:-0.024751901626587
name:-0.021926879882812
name:-0.0092301368713379
MAO; Long Patent Filings

MAO; Long

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAO; Long.The latest application filed is for "process for manufacture of (s)-n-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-- methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereof".

Company Profile
9.20.23
  • MAO; Long - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Process for Manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-- methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and Formulations Thereof
App 20210309642 - MAO; Long ;   et al.
2021-10-07
Pharmaceutical Salts, Physical Forms, And Compositions Of Pyrrolopyrimidine Kinase Inhibitors, And Methods Of Making Same
App 20210300931 - MAO; Long ;   et al.
2021-09-30
EGFR modulators and uses thereof
Grant 11,007,197 - Xu , et al. May 18, 2
2021-05-18
Heterocyclic Compounds And Uses As Anticancer Agents
App 20210100802 - XU; Xiao ;   et al.
2021-04-08
Heterocyclic compounds and uses as anticancer agents
Grant 10,799,504 - Xu , et al. October 13, 2
2020-10-13
Novel Egfr Modulators And Uses Thereof
App 20200129516 - XU; Xiao ;   et al.
2020-04-30
Pyrrolopyrimidine compounds as inhibitors of protein kinases
Grant 10,596,174 - Xu , et al.
2020-03-24
Heterocyclic compounds and uses thereof
Grant 10,562,918 - Xu , et al. Feb
2020-02-18
Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making same
Grant 10,533,011 - Mao , et al. Ja
2020-01-14
EGFR modulators and uses thereof
Grant 10,449,196 - Xu , et al. Oc
2019-10-22
Pharmaceutical Salts, Physical Forms, And Compositions Of Pyrrolopyrimidine Kinase Inhibitors, And Methods Of Making Same
App 20180312510 - MAO; Long ;   et al.
2018-11-01
Heterocyclic Compounds And Uses Thereof
App 20180251475 - XU; Xiao ;   et al.
2018-09-06
Heterocyclic compounds and uses thereof
Grant 9,920,074 - Xu , et al. March 20, 2
2018-03-20
Novel Egfr Modulators And Uses Thereof
App 20180008607 - XU; Xiao ;   et al.
2018-01-11
EGFR modulators and uses thereof
Grant 9,763,949 - Xu , et al. September 19, 2
2017-09-19
Novel Pyrrolopyrimidine Compounds As Inhibitors Of Protein Kinases
App 20170224689 - XU; Xiao ;   et al.
2017-08-10
Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinases
Grant 9,586,965 - Xu , et al. March 7, 2
2017-03-07
Heterocyclic Compounds And Uses Thereof
App 20170029442 - XU; Xiao ;   et al.
2017-02-02
Heterocyclic compounds and uses thereof
Grant 9,464,089 - Xu , et al. October 11, 2
2016-10-11
Novel Egfr Modulators And Uses Thereof
App 20150246047 - XU; Xiao ;   et al.
2015-09-03
Novel Pyrrolopyrimidine Compounds As Inhibitors Of Protein Kinases
App 20150210702 - Xu; Xiao ;   et al.
2015-07-30
EGFR modulators and uses thereof
Grant 9,034,885 - Xu , et al. May 19, 2
2015-05-19
Heterocyclic Compounds And Uses Thereof
App 20150133457 - XU; Xiao ;   et al.
2015-05-14
EGFR modulators and uses thereof
Grant 8,685,988 - Xu , et al. April 1, 2
2014-04-01
Novel Egfr Modulators And Uses Thereof
App 20140038981 - XU; Xiao ;   et al.
2014-02-06
Novel Egfr Modulators And Uses Thereof
App 20140038940 - XU; Xiao ;   et al.
2014-02-06
Heterocyclic Compounds And Uses As Anticancer Agents
App 20130190320 - XU; Xiao ;   et al.
2013-07-25
.alpha.-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
Grant 8,119,680 - Cheng , et al. February 21, 2
2012-02-21
Compounds and uses thereof in modulating amyloid .beta.
Grant 8,017,629 - Cheng , et al. September 13, 2
2011-09-13
Heterocyclic Compounds And Uses As Anticancer Agents
App 20110207751 - Mao; Long ;   et al.
2011-08-25
Alpha-haloketone Derivatives Of Imidazolyl-substituted Aromatic Compounds And Compounds Prepared Therefrom
App 20100331551 - Cheng; Soan ;   et al.
2010-12-30
Compounds And Uses Thereof In Modulating Amyloid Beta
App 20100324032 - Cheng; Soan ;   et al.
2010-12-23
.alpha.-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom
Grant 7,799,808 - Cheng , et al. September 21, 2
2010-09-21
Compounds and uses thereof in modulating amyloid beta
Grant 7,781,442 - Cheng , et al. August 24, 2
2010-08-24
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
Grant 7,297,708 - Termin , et al. November 20, 2
2007-11-20
Compounds and Uses Thereof in Modulating Amyloid Beta
App 20070260058 - Cheng; Soan ;   et al.
2007-11-08
Compounds And Uses Thereof In Modulating Amyloid Beta
App 20070249833 - Cheng; Soan ;   et al.
2007-10-25
Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands
Grant 7,276,526 - Termin , et al. October 2, 2
2007-10-02
Compounds and uses thereof in modulating amyloid beta
Grant 7,244,739 - Cheng , et al. July 17, 2
2007-07-17
2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists
Grant 6,984,643 - Du Bois , et al. January 10, 2
2006-01-10
Compounds and uses thereof in modulating amyloid beta
App 20050070538 - Cheng, Soan ;   et al.
2005-03-31
2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists
App 20040014775 - Du Bois, Daisy Joe ;   et al.
2004-01-22
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
App 20030229091 - Termin, Andreas ;   et al.
2003-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed